Krensavage Asset Management

Latest statistics and disclosures from Krensavage Asset Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Krensavage Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Krensavage Asset Management

Krensavage Asset Management holds 12 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Exelixis (EXEL) 16.2 $46M 1.9M 23.99
 View chart
United Therapeutics Corporation (UTHR) 15.7 $44M 201k 219.89
 View chart
Biogen Idec (BIIB) 14.7 $42M 161k 258.77
 View chart
Regeneron Pharmaceuticals (REGN) 14.7 $42M 47k 878.28
 View chart
Cardinal Health (CAH) 10.1 $28M -3% 282k 100.80
 View chart
Taro Pharmaceutical Industries (TARO) 9.6 $27M 647k 41.78
 View chart
Alkermes (ALKS) 9.0 $26M 918k 27.74
 View chart
Jazz Pharmaceuticals (JAZZ) 4.4 $12M NEW 100k 123.00
 View chart
Sanofi-Aventis SA (SNY) 2.7 $7.5M NEW 150k 49.73
 View chart
Enanta Pharmaceuticals (ENTA) 2.5 $7.0M 743k 9.41
 View chart
Masimo Corporation (MASI) 0.3 $938k NEW 8.0k 117.25
 View chart
Mural Oncology 0.2 $538k NEW 91k 5.92
 View chart

Past Filings by Krensavage Asset Management

SEC 13F filings are viewable for Krensavage Asset Management going back to 2014

View all past filings